{"concreteType":"org.sagebionetworks.repo.model.table.QueryResultBundle","queryResult":{"concreteType":"org.sagebionetworks.repo.model.table.QueryResult","queryResults":{"headers":[{"columnType":"STRING","name":"projectName","id":"70035"},{"columnType":"ENTITYID","name":"id","id":"2510"},{"columnType":"STRING","name":"fundingAgency","id":"62359"},{"columnType":"STRING","name":"citation","id":"70036"},{"columnType":"STRING","name":"doi","id":"70037"},{"columnType":"STRING","name":"tumorType","id":"38871"},{"columnType":"STRING","name":"diseaseFocus","id":"62360"}],"concreteType":"org.sagebionetworks.repo.model.table.RowSet","tableId":"syn16857542","etag":"3e3a9003-962f-4cd2-96ac-dacbe3c45595","rows":[{"values":["Child NF1 Quality of Life Measures","syn4939878","NTAP","Nutakki K et al. Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods. J Neurooncol (2017)","10.1007/s11060-016-2351-2;10.1111/jspn.12174","Plexiform Neurofibroma","Neurofibromatosis 1"],"versionNumber":0,"rowId":2},{"values":["Child NF1 Quality of Life Measures","syn4939878","NTAP","Draucker CB et al. The health-related quality of life of children, adolescents, and young adults with neurofibromatosis type 1 and their families: Analysis of narratives. J Spec Pediatr Nurs (2017).","10.1007/s11060-016-2351-2;10.1111/jspn.12174","Plexiform Neurofibroma","Neurofibromatosis 1"],"versionNumber":0,"rowId":3},{"values":["Drug Screening of pNF Cell Lines","syn4939906","NTAP","Ferrer M, et al. Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells. Nature Sci Data (2018).","10.1038/sdata.2018.106","Plexiform Neurofibroma","Neurofibromatosis 1"],"versionNumber":0,"rowId":4},{"values":["NF1 Dermal Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial","syn8012530","NTAP","Cannon A, et al. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study. Orphanet J Rare Dis (2018).","10.1186/s13023-018-0772-z","Cutaneous Neurofibroma","Neurofibromatosis 1"],"versionNumber":0,"rowId":5},{"values":["Plexiform Neurofibroma Model Systems for Preclinical Drug Screening","syn7217928","NTAP","Brock EJ, Ji K, Reiners JJ Jr. & Mattingly RR. How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization. Mini Rev Med Chem. 2016 ; 16(5): 358-369.","10.2174/1389557515666151001154002","Plexiform Neurofibroma","Neurofibromatosis 1"],"versionNumber":0,"rowId":11},{"values":["pNF Cell Line Characterization Studies","syn4939874","NTAP","Ferrer M, et al. Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells. Nature Sci Data (2018).","10.1038/sdata.2018.106","Plexiform Neurofibroma","Neurofibromatosis 1"],"versionNumber":0,"rowId":12}]}},"selectColumns":[{"columnType":"STRING","name":"projectName","id":"70035"},{"columnType":"ENTITYID","name":"id","id":"2510"},{"columnType":"STRING","name":"fundingAgency","id":"62359"},{"columnType":"STRING","name":"citation","id":"70036"},{"columnType":"STRING","name":"doi","id":"70037"},{"columnType":"STRING","name":"tumorType","id":"38871"},{"columnType":"STRING","name":"diseaseFocus","id":"62360"}],"columnModels":[{"columnType":"STRING","name":"projectName","maximumSize":89,"id":"70035"},{"columnType":"ENTITYID","name":"id","id":"2510"},{"columnType":"STRING","facetType":"enumeration","name":"fundingAgency","maximumSize":4,"id":"62359"},{"columnType":"STRING","name":"citation","maximumSize":198,"id":"70036"},{"columnType":"STRING","name":"doi","maximumSize":44,"id":"70037"},{"columnType":"STRING","facetType":"enumeration","name":"tumorType","maximumSize":22,"id":"38871"},{"columnType":"STRING","facetType":"enumeration","name":"diseaseFocus","maximumSize":19,"id":"62360"}],"facets":[{"facetType":"enumeration","facetValues":[{"count":6,"isSelected":false,"value":"NTAP"}],"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"fundingAgency"},{"facetType":"enumeration","facetValues":[{"count":1,"isSelected":false,"value":"Cutaneous Neurofibroma"},{"count":5,"isSelected":false,"value":"Plexiform Neurofibroma"}],"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"tumorType"},{"facetType":"enumeration","facetValues":[{"count":6,"isSelected":false,"value":"Neurofibromatosis 1"}],"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"diseaseFocus"}]}